According to Shanghai RAAS Blood Products's latest financial reports the company's current revenue (TTM ) is $1.09 Billion USD. In 2024 the company made a revenue of $1.13 Billion USD an increase over the revenue in the year 2023 that were of $1.12 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.